Christine Bellon

Companies

• Beam TherapeuticsGeneral counsel Mar 27, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Beam Therapeutics BEAM109,711 shares²$2.6M at $24.00Apr 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 1, 2026Sold 5,956 shares at $24.58 of Beam Therapeutics²
• Mar 31, 2026Granted 20,000 shares of Beam Therapeutics³
• Jan 22, 2026Sold 1,371 shares at $34.00 of Beam Therapeutics⁴
• Jan 15, 2026Sold 559 shares at $35.40 of Beam Therapeutics⁵
• Jan 15, 2026Sold 15,959 shares at $34.72 of Beam Therapeutics⁵
• Jan 15, 2026Sold 2,111 shares at $33.62 of Beam Therapeutics⁵
• Dec 31, 2025Sold 1,254 shares at $27.10 of Beam Therapeutics⁶
• Oct 1, 2025Sold 373 shares at $24.53 of Beam Therapeutics⁷
• Apr 1, 2025Sold 5,674 shares at $18.35 of Beam Therapeutics⁸
• Mar 31, 2025Granted 20,000 shares of Beam Therapeutics⁹
• Feb 14, 2025Sold 10,000 shares at $34.00 of Beam Therapeutics¹⁰
• Feb 14, 2025Exercised options 508 shares at $7.22 of Beam Therapeutics¹⁰
• Feb 14, 2025Exercised options 9,492 shares at $7.22 of Beam Therapeutics¹⁰
• Jan 2, 2025Sold 1,241 shares at $24.68 of Beam Therapeutics¹¹
• Oct 1, 2024Sold 385 shares at $23.48 of Beam Therapeutics¹²
• Apr 1, 2024Sold 3,401 shares at $32.12 of Beam Therapeutics¹³
• Mar 31, 2024Granted 27,500 shares of Beam Therapeutics¹⁴
• Jan 3, 2024Sold 1,907 shares at $26.42 of Beam Therapeutics¹⁵
• Nov 20, 2023Sold 5,000 shares at $31.00 of Beam Therapeutics¹⁶
• Nov 20, 2023Sold 5,000 shares at $30.00 of Beam Therapeutics¹⁶
• Nov 20, 2023Exercised options 5,818 shares at $7.22 of Beam Therapeutics¹⁶
• Nov 20, 2023Exercised options 4,182 shares at $7.22 of Beam Therapeutics¹⁶
• Oct 2, 2023Sold 388 shares at $22.85 of Beam Therapeutics¹⁷
• Apr 4, 2023Sold 1,161 shares at $29.09 of Beam Therapeutics¹⁸
• Apr 3, 2023Sold 931 shares at $30.31 of Beam Therapeutics¹⁸